Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia

Vascular Medicine

Volumn 14, Issue 1, 2009, Pages 29-36

  Ruifrok, Willem Peter T ^a,b   de Boer, Rudolf A ^a   Iwakura, Atsushi ^b   Silver, Marcy ^b   Kusano, Kengo ^b   Tio, Rene A ^a   Losordo, Douglas W ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Endothelial progenitor cell; Estrogen; Neovascularization

Indexed keywords

ANGIOPOIETIN RECEPTOR; BETA GALACTOSIDASE; ESTRADIOL; PLACEBO;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL COUNT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; FUNCTIONAL STATUS; HINDLIMB; LEG BLOOD FLOW; LEG ISCHEMIA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION; TRANSGENIC ANIMAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BETA-GALACTOSIDASE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CAPILLARIES; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ENDOTHELIAL CELLS; ESTRADIOL; HINDLIMB; ISCHEMIA; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS, GENETIC; RECEPTOR, TIE-2; REGIONAL BLOOD FLOW; STEM CELLS; TIME FACTORS;

EID: 58549101921     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X08096666     Document Type: Article

References (50)

1. Asahara T Murohara T Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Amrani DL Port S. Cardiovascular disease: Potential impact of stem cell therapy. Expert Rev Cardiovasc Ther 2003; 1: 453-461.
3. Dobert N Britten M Assmus B. Transplantation of progenitor cells after reperfused acute myocardial infarction: Evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 2004; 31: 1146-1151.
4. Iwaguro H Yamaguchi J Kalka C. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002; 105: 732-738.
5. Iwakura A Luedemann C Shastry S. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003; 108: 3115-3121.
6. Kudo FA Nishibe T Nishibe M Yasuda K. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 2003; 22: 344-348.
7. Krasinski K Spyridopoulos I Asahara T van der Zee R Isner JM Losordo DW. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997; 95: 1768-1772.
8. Reyes M Dudek A Jahagirdar B Koodie L Marker PH Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337-346.
9. Shi Q Rafii S Wu MH. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
10. Takahashi T Kalka C Masuda H. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
11. Hamada H Kim MK Iwakura A. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 2006; 114: 2261-2270.
12. Iwakura A Shastry S Luedemann C. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 2006; 113: 1605-1614.
13. Shifren JL Tseng JF Zaloudek CJ. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81: 3112-3118.
14. Findlay JK. Angiogenesis in reproductive tissues. J Endocrinol 1986; 111: 357-366.
15. Koos RD Le Maire WJ. Factors that may regulate the growth and regression of blood vessels in the ovary. Semin Reprod Endocrinol 1983; 1: 295-307.
16. Reynolds LP Killielea SD Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992; 6: 886-892.
17. Goede V Schmidt T Kimmina S Kozian D Augustin HG. Analysis of blood vessel maturation process during cyclic ovarian angiogenesis. Lab Invest 1998; 78: 1385-1394.
18. Losordo DW Isner JM. Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 2001; 21: 6-12.
19. Garcia PM Gimenez J Bonacasa B. 17beta-estradiol exerts a beneficial effect on coronary vascular remodeling in the early stages of hypertension in spontaneously hypertensive rats. Menopause 2005; 12: 453-459.
20. Miller AP Feng W Xing D. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004; 110: 1664-1669.
21. Patten RD Pourati I Aronovitz MJ. 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004; 95: 692-699.
22. Strehlow K Werner N Berweiler J. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
23. Goukassian DA Qin G Dolan C. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 2007; 115: 752-762.
24. Asahara T Takahashi T Masuda H. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
25. Hirsch AT Criqui MH Treat-Jacobson D. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.
26. Criqui MH Vargas V Denenberg JO. Ethnicity and peripheral arterial disease: The San Diego Population Study. Circulation 2005; 112: 2703-2707.
27. Selvin E Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110: 738-743.
28. Mendelsohn ME Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
29. Nikolic I Liu D Bell JA Collins J Steenbergen C Murphy E. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 2007; 42: 769-780.
30. Urata Y Ihara Y Murata H. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J Biol Chem 2006; 281: 13092-13102.
31. Shinohara T Takahashi N Ooie T. Estrogen inhibits hyperthermia-induced expression of heat-shock protein 72 and cardioprotection against ischemia/reperfusion injury in female rat heart. J Mol Cell Cardiol 2004; 37: 1053-1061.
32. Zhai P Eurell TE Cotthaus R Jeffery EH Bahr JM Gross DR. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol 2000; 279: H2766-H2775.
33. Beer S Reincke M Kral M. High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. Basic Res Cardiol 2007; 102: 9-18.
34. Satoh M Matter CM Ogita H. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 2007; 115: 3197-3204.
35. Kim JK Pedram A Razandi M Levin ER. Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem 2006; 281: 6760-6767.
36. Hopkins SP Bulgrin JP Sims RL Bowman B Donovan DL Schmidt SP. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg 1998; 27: 886-894 discussion 95.
37. Kyriakides ZS Petinakis P Kaklamanis L. Gender does not influence angiogenesis and arteriogenesis in a rabbit model of chronic hind limb ischemia. Int J Cardiol 2003; 92: 83-91.
38. Kyriakides ZS Petinakis P Kaklamanis L. Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia. Cardiovasc Res 2001; 49: 626-633.
39. Senthilkumar A Smith RD Khitha J. Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway. Arterioscler Thromb Vasc Biol 2007; 27: 1947-1954.
40. Tiidus PM Deller M Bombardier E Gul M Liu XL. Estrogen supplementation failed to attenuate biochemical indices of neutrophil infiltration or damage in rat skeletal muscles following ischemia. Biol Res 2005; 38: 213-223.
41. Di Stefano R Santoni T Barsotti MC. Different growth conditions for peripheral blood endothelial progenitors. Cardiovasc Radiat Med 2002; 3: 172-175.
42. Kalka C Masuda H Takahashi T. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000; 86: 1198-1202.
43. Silvestre JS Tamarat R Ebrahimian TG. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 2003; 93: 114-123.
44. Yoon YS Losordo DW. All in the family: VEGF-B joins the ranks of proangiogenic cytokines. Circ Res 2003; 93: 87-90.
45. Yamaguchi J Kusano KF Masuo O. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322-1328.
46. Llevadot J Murasawa S Kureishi Y. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399-405.
47. Bahlmann FH De Groot K Spandau JM. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926.
48. Heeschen C Aicher A Lehmann R. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346.
49. Westenbrink BD Lipsic E van der Meer P. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 2007; 28: 2018-2027.
50. Booth EA Obeid NR Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol 2005; 289: H2039-H2047.